MS, COVID-19 and vaccines – updated global advice
Advice for people with MS - updated on 21 March
An update from the MS Global Data Sharing Initiative – Thank You!
When we come together, we can find answers, quickly, to global MS challenges.
How do people with MS respond to COVID-19 vaccines?
What does research tell us about how DMTs affect the body’s immune response to COVID-19 vaccines?
The power of translation: making MS information accessible
Discover how MS organisations collaborate to translate vital MS information.
How £513,000 is supporting 21 MS organisations through the pandemic
Six months into the COVID-19 Response Initiative
How do different DMTs affect people’s COVID-19 vaccine response?
Researchers in Israel have published the results of a small study exploring how well the Pfizer-BioNtech COVID-19 vaccine protects people with MS taking cladribine, fingolimod or ocrelizumab.
MSIF grants £500,000 to MS organisations through the COVID-19 Response Initiative
MSIF grants over £500,000 to MS organisations to help them through the pandemic.
Could the science behind a vaccine be used to treat MS?
Could a vaccine treat MS?
Ten months in: the COVID-19 and MS global data sharing initiative
A look back at what the global MS movement has achieved during the pandemic.
Thank you masks from Brazil
The COVID-19 pandemic has brought unprecedented challenges to MS organisations across the world, and the Associação Brasileira de Esclerose Múltipla (ABEM) in Brazil is no exception.
Responding to the data: new global COVID-19 advice for people with MS
Updated global advice for people with MS and the data behind it
MS research awards: deadline extended to 31 August
Finding the answers to COVID-19 & MS : Your role in the global effort
Register now: a webinar for people with MS and MS organisations – your questions answered on the COVID-19 & MS global data sharing initiative
MS data sharing during the coronavirus pandemic
Sharing data to find answers quicker during COVID-19
A message of global solidarity during COVID-19
A message from the CEO of the MS International Federation as the global MS community faces the challenges of the coronavirus